申请人:Celtaxsys, Inc.
公开号:US20160272649A1
公开(公告)日:2016-09-22
This invention is directed to compounds of formula (I):
where r, q, R, R
2
, R
3
, R
4
, R
5a
, R
5b
, R
5c
, R
6a
, R
6b
, R
6c
, R
7
, R
8
, and R
9
are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A
4
hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.
本发明涉及化合物的公式(I):
其中r,q,R,R2,R3,R4,R5a,R5b,R5c,R6a,R6b,R6c,R7,R8和R9如本文所述,可以作为单一立体异构体或立体异构体混合物,或其药学上可接受的盐,溶剂合物,笼合物,多晶形式,铵离子,N-氧化物或其前药; 这些化合物是白三烯A4水解酶抑制剂,因此在治疗炎症性疾病方面有用。本发明还揭示了包含该化合物的制药组合物以及制备该化合物的方法。